174 related articles for article (PubMed ID: 12015196)
21. [Renal biopsy: standard procedure of modern nephrology].
Thut MP; Uehlinger D; Steiger J; Mihatsch MJ
Ther Umsch; 2002 Mar; 59(3):110-6. PubMed ID: 11975398
[TBL] [Abstract][Full Text] [Related]
22. Furosemide-albumin complexes in refractory nephrotic syndrome and chronic renal failure.
Mattana J; Patel A; Ilunga C; Singhal PC
Nephron; 1996; 73(1):122-3. PubMed ID: 8742982
[No Abstract] [Full Text] [Related]
23. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
[TBL] [Abstract][Full Text] [Related]
24. Renal disease in diabetics--which patients have diabetic nephropathy and what is their outcome?
Lynn KL; Frendin TJ; Walker RJ; Bailey RR; Swainson CP
Aust N Z J Med; 1988 Oct; 18(6):764-7. PubMed ID: 3242462
[TBL] [Abstract][Full Text] [Related]
25. Reversible acute renal failure in idiopathic nephrotic syndrome.
Furuya R; Kumagai H; Ikegaya N; Kobayashi S; Kimura M; Hishida A; Kaneko E
Intern Med; 1993 Jan; 32(1):31-5. PubMed ID: 8495041
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
[TBL] [Abstract][Full Text] [Related]
27. Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes.
Goldman M; Hébert D; Geary DF
Pediatr Nephrol; 2002 May; 17(5):351-4. PubMed ID: 12042892
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
[TBL] [Abstract][Full Text] [Related]
29. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
Chiarelli F; Verrotti A; Mohn A; Morgese G
Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
[TBL] [Abstract][Full Text] [Related]
30. Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.
Lee TH; Kuo G; Chang CH; Huang YT; Yen CL; Lee CC; Fan PC; Chen JJ
PLoS One; 2021; 16(12):e0260312. PubMed ID: 34851962
[TBL] [Abstract][Full Text] [Related]
31. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
32. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N
Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
[TBL] [Abstract][Full Text] [Related]
33. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.
Sirivella S; Gielchinsky I; Parsonnet V
Ann Thorac Surg; 2000 Feb; 69(2):501-6. PubMed ID: 10735688
[TBL] [Abstract][Full Text] [Related]
34. Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury.
Jeon J; Kim DH; Baeg SI; Lee EJ; Chung CR; Jeon K; Lee JE; Huh W; Suh GY; Kim YG; Kim DJ; Oh HY; Jang HR
Crit Care; 2018 Oct; 22(1):255. PubMed ID: 30305122
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome.
Haws RM; Baum M
Pediatrics; 1993 Jun; 91(6):1142-6. PubMed ID: 8502517
[TBL] [Abstract][Full Text] [Related]
36. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.
Hebert LA; Bain RP; Verme D; Cattran D; Whittier FC; Tolchin N; Rohde RD; Lewis EJ
Kidney Int; 1994 Dec; 46(6):1688-93. PubMed ID: 7700028
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of nephrotic syndrome.
McCloskey O; Maxwell AP
Practitioner; 2017 Feb; 261(1801):11-5. PubMed ID: 29020719
[TBL] [Abstract][Full Text] [Related]
38. Tetracycline-induced acute interstitial nephritis as a cause of acute renal failure.
Bihorac A; Ozener C; Akoglu E; Kullu S
Nephron; 1999 Jan; 81(1):72-5. PubMed ID: 9884423
[TBL] [Abstract][Full Text] [Related]
39. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous remission of the nephrotic syndrome in diabetic nephropathy.
Pabico RC; Panner BJ; McKenna BA; Freeman RB
Am J Med; 1975 Sep; 59(3):434-43. PubMed ID: 1163552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
